Urge your members of Congress to support continued medical research funding
ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.
A multi-faceted initiative to identify the highest priority actions needed to improve the outcomes for individuals with SCD in the U.S. and globally.
Urge your members of Congress to support continued medial research funding.
Provides opportunities to learn more about advocacy, health policy, and the legislative process, and to become engaged in the Society’s activities.
Provides education about the policy making process, including Congress’ relationship to the hematology community.
Get an overview of the Medicare Access and CHIP Reauthorization Act (MACRA) and its impact on hematology.
Keep informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.
President Trump’s fiscal year (FY) 2018 budget outline seeks massive cuts to federal non-defense discretionary (NDD) programs including the National Institutes of Health (NIH). Your elected officials need to hear from you about the importance of sustained and predictable NIH funding.
The Cancer Treatment Fairness Act (H.206) would require any health plan that provides coverage for cancer chemotherapy treatment to provide coverage for orally administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port-administered, or injected anticancer medications. It is important you reach out to ask for your North Carolina state Senator's support.
Legislation has been introduced in the U.S. House of Representatives that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens. Your Senators and Representative need to cosponsor these bills in order for them to be considered by the full Congress.
ASH submitted comments to the NIH on hematology-related pediatric research that should be included in the NIH's All of Us research program.
After spending months crafting legislation to repeal and
replace the Affordable Care Act (ACA), in late July, the U.S. Senate had its
chance to vote on and pass repeal legislation.
The National Center for Advancing Translational Sciences (NCATS) released a request for information soliciting input on the use of viral vectors as platforms for therapeutic gene delivery to specific organs or cell types, and how such platforms might be developed most efficiently in clinical trials for the treatment of multiple diseases.
On July 13, 2017, the U.S. Senate released an updated
version of the Better Care Reconciliation Act (BCRA), legislation to repeal
large provisions of the Affordable Care Act (ACA).
Join the Grassroots Network to stay up to date on all of ASH’s Advocacy Campaigns.
Become an advocate for hematology with our easy-to-use advocacy resources.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology